Literature DB >> 9097054

Mammographic patterns of inflammatory breast carcinoma: a retrospective study of 92 cases.

A A Tardivon1, J Viala, A Corvellec Rudelli, J M Guinebretiere, D Vanel.   

Abstract

OBJECTIVE: To quantitate initial mammographic signs and to describe post-therapeutic patterns of inflammatory breast cancer.
MATERIAL AND METHODS: Two radiologists retrospectively analyzed the initial clinical and mammographic findings of 92 patients with inflammatory breast carcinoma. The post-therapeutic mammogram (n = 75) was considered abnormal when focal opacity and or malignant-type microcalcifications were still visible.
RESULTS: Redness of the skin, "peau d'orange' and increased temperature were the most common findings. A palpable mass was noted in 97% with axillary lymph node involvement in 83% of cases. All initial mammograms were abnormal. Isolated inflammatory signs were observed in 14% and malignant signs in 86% of patients (opacity = 77% and/or malignant-type microcalcifications = 47%). Skin thickening was seen in 93.5%, nipple inversion in 56.5%, increased breast density in 93.5%, stromal coarsening in 85% and hypervascularisation in 32.5% of mammograms. On post-therapeutic mammograms, 35 patients (46.5%) were suspected of having residual disease. During follow-up, 19 patients (25.3%) relapsed locally: 75% had abnormal post-therapeutic mammograms.
CONCLUSION: The presence of isolated inflammatory signs on the mammogram is sufficient to suspect inflammatory breast carcinoma and biopsy must be performed in doubtful cases. Radical surgery is indicated when persistent malignant signs are still visible on mammogram after conservative treatment.

Entities:  

Mesh:

Year:  1997        PMID: 9097054     DOI: 10.1016/s0720-048x(96)01137-0

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  8 in total

1.  Inflammatory breast carcinoma and locally advanced breast carcinoma: characterisation with MR imaging.

Authors:  V Girardi; G Carbognin; L Camera; F Bonetti; E Manfrin; G Pollini; R Pozzi Mucelli
Journal:  Radiol Med       Date:  2010-10-06       Impact factor: 3.469

2.  Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute.

Authors:  Kenneth W Hance; William F Anderson; Susan S Devesa; Heather A Young; Paul H Levine
Journal:  J Natl Cancer Inst       Date:  2005-07-06       Impact factor: 13.506

3.  Inflammatory breast cancer: MR imaging findings.

Authors:  G Carbognin; C Calciolari; V Girardi; L Camera; G Pollini; R Pozzi Mucelli
Journal:  Radiol Med       Date:  2009-12-16       Impact factor: 3.469

4.  18-Fluorodeoxyglucose-positron emission tomography in inflammatory breast cancer.

Authors:  Muna M Baslaim; Siema M Bakheet; Razan Bakheet; Adnan Ezzat; Mahmoud El-Foudeh; Asma Tulbah
Journal:  World J Surg       Date:  2003-08-18       Impact factor: 3.352

5.  Influence of patient, physician, and hospital characteristics on the receipt of guideline-concordant care for inflammatory breast cancer.

Authors:  Ryan A Denu; John M Hampton; Adam Currey; Roger T Anderson; Rosemary D Cress; Steven T Fleming; Joseph Lipscomb; Susan A Sabatino; Xiao-Cheng Wu; J Frank Wilson; Amy Trentham-Dietz
Journal:  Cancer Epidemiol       Date:  2015-11-21       Impact factor: 2.984

6.  Non-puerperal mastitis masking pre-existing breast malignancy: importance of follow-up imaging.

Authors:  Jin Kyung An; Jeong Joo Woo; Seung A Lee
Journal:  Ultrasonography       Date:  2015-06-11

Review 7.  Unilateral breast edema: spectrum of etiologies and imaging appearances.

Authors:  Jin Young Kwak; Eun Kyung Kim; Sun Yang Chung; Jai Kyung You; Ki Keun Oh; Yong Hee Lee; Tae Hee Kwon; Hae Kyoung Jung
Journal:  Yonsei Med J       Date:  2005-02-28       Impact factor: 2.759

8.  First description of feline inflammatory mammary carcinoma: clinicopathological and immunohistochemical characteristics of three cases.

Authors:  M Dolores Pérez-Alenza; Angeles Jiménez; Ana I Nieto; Laura Peña
Journal:  Breast Cancer Res       Date:  2004-04-26       Impact factor: 6.466

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.